Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

NCT00120419 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: mycophenol mofetil (MMF, Cellcept®) 500 mg BID

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]
[object Object]